PACIRA BIOSCIENCES, INC. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
PACIRA BIOSCIENCES, INC. (PCRX) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 366.65 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2026-06-30 was 156.50K shares.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2026-03-31 was 210.15K shares.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2025-12-31 was 6.69K shares.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2025-09-30 was 315.00 shares.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2025 was 217.11K shares, a 1072.38% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2024 was 18.52K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | 156.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 366.65K shares 10-Q · filed 2026-08-04 | 373.34K shares derived: sum of 3 quarters · filed 2026-08-04 | 373.65K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 210.15K shares 10-Q · filed 2026-04-30 | 216.84K shares derived: sum of 2 quarters · filed 2026-04-30 | 217.15K shares derived: sum of 3 quarters · filed 2026-04-30 | |
| 2025-12-31 | 6.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 7.00K shares derived: sum of 2 quarters · filed 2026-02-26 | 217.11K shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 315.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 210.42K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 210.11K shares 10-Q · filed 2025-08-05 | |||
| 2024-12-31 | 18.52K shares 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |